U.S. Markets close in 5 hrs 40 mins

Eiger BioPharmaceuticals, Inc. (EIGR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.07-0.23 (-2.20%)
As of 10:20AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.34
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 315.82
52 Week Low 34.55
50-Day Moving Average 311.05
200-Day Moving Average 39.67

Share Statistics

Avg Vol (3 month) 3438.19k
Avg Vol (10 day) 3429.07k
Shares Outstanding 525.06M
Float 24.9M
% Held by Insiders 11.70%
% Held by Institutions 185.05%
Shares Short (Aug 30, 2020) 41.21M
Short Ratio (Aug 30, 2020) 42.54
Short % of Float (Aug 30, 2020) 44.22%
Short % of Shares Outstanding (Aug 30, 2020) 44.14%
Shares Short (prior month Jul 30, 2020) 4821.47k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Mar 22, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.45%
Return on Equity (ttm)-90.20%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -63.05M
Net Income Avi to Common (ttm)-66.1M
Diluted EPS (ttm)-2.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)90.78M
Total Cash Per Share (mrq)3.1
Total Debt (mrq)32.35M
Total Debt/Equity (mrq)55.31
Current Ratio (mrq)6.03
Book Value Per Share (mrq)2.15

Cash Flow Statement

Operating Cash Flow (ttm)-63.12M
Levered Free Cash Flow (ttm)-39.45M